These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 6391885)

  • 21. Simultaneous determination of vancomycin and ceftazidime in cerebrospinal fluid in craniotomy patients by high-performance liquid chromatography.
    Ye G; Cai X; Wang B; Zhou Z; Yu X; Wang W; Zhang J; Wang Y; Dong J; Jiang Y
    J Pharm Biomed Anal; 2008 Nov; 48(3):860-5. PubMed ID: 18657374
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Continuous infusion of ceftazidime with an elastomeric infusion device.
    Couldry R; Sanborn M; Klutman NE; Strayer AH
    Am J Health Syst Pharm; 1998 Jan; 55(2):145-9. PubMed ID: 9465978
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determination of cephazolin, ceftazidime, and ceftriaxone distribution in nucleus pulposus.
    Yan D; Li J; Zhang Z; Zhu H
    Arch Orthop Trauma Surg; 2012 Jul; 132(7):969-73. PubMed ID: 22526195
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pharmacokinetic studies of ceftazidime in serum, bone, bile, tissue fluid and peritoneal fluid.
    Wittmann DH; Schassan HH; Kohler F; Seibert W
    J Antimicrob Chemother; 1981 Sep; 8 Suppl B():293-7. PubMed ID: 19803001
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Experimental and clinical evaluation of the biliary elimination of ceftazidime].
    Brogard JM; Jehl F; Blickle JF; Monteil H; Arnaud JP
    Pathol Biol (Paris); 1986 May; 34(5):332-8. PubMed ID: 3534701
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intraventricular immunotoxin therapy for leptomeningeal neoplasia.
    Laske DW; Muraszko KM; Oldfield EH; DeVroom HL; Sung C; Dedrick RL; Simon TR; Colandrea J; Copeland C; Katz D; Greenfield L; Groves ES; Houston LL; Youle RJ
    Neurosurgery; 1997 Nov; 41(5):1039-49; discussion 1049-51. PubMed ID: 9361057
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Neuroprotein dynamics in the cerebrospinal fluid: intraindividual concomitant ventricular and lumbar measurements.
    Brandner S; Thaler C; Lewczuk P; Lelental N; Buchfelder M; Kleindienst A
    Eur Neurol; 2013; 70(3-4):189-94. PubMed ID: 23969528
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Pharmacokinetics of ceftazidime in acutely ill hospitalised elderly patients.
    Jonsson M; Walder M
    Eur J Clin Microbiol Infect Dis; 1992 Jan; 11(1):15-21. PubMed ID: 1563378
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Penetration of ceftazidime into intracranial abscess.
    Green HT; O'Donoghue MA; Shaw MD; Dowling C
    J Antimicrob Chemother; 1989 Sep; 24(3):431-6. PubMed ID: 2681122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Changes in cerebrospinal fluid hydrodynamics following endoscopic third ventriculostomy for shunt-dependent noncommunicating hydrocephalus.
    Nishiyama K; Mori H; Tanaka R
    J Neurosurg; 2003 May; 98(5):1027-31. PubMed ID: 12744362
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Prognostic significance of ventricular CSF lactic acidosis in severe head injury.
    DeSalles AA; Kontos HA; Becker DP; Yang MS; Ward JD; Moulton R; Gruemer HD; Lutz H; Maset AL; Jenkins L
    J Neurosurg; 1986 Nov; 65(5):615-24. PubMed ID: 3772448
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Ventricular cerebrospinal fluid concentrations of trimethoprim-sulphamethoxazole.
    Wang EE; Prober CG
    J Antimicrob Chemother; 1983 Apr; 11(4):385-9. PubMed ID: 6602124
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Ceftazidime in the treatment of Pseudomonas infections in intensive-care patients.
    Rondanelli R; Dionigi RV; Regazzi MB; Maurelli M; Calvi M; Mapelli A
    Int J Clin Pharmacol Ther Toxicol; 1986 Sep; 24(9):457-9. PubMed ID: 3536763
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Ceftazidime concentration in human prostatic tissue and serum following intravenous injection].
    Morita M; Hatakeyama T; Suzuki K
    Hinyokika Kiyo; 1991 Jun; 37(6):659-62. PubMed ID: 1716410
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Serum and sputum concentrations of ceftazidime in patients with cystic fibrosis.
    Turner A; Pedler SJ; Carswell F; Spencer GR; Speller DC
    J Antimicrob Chemother; 1984 Nov; 14(5):521-7. PubMed ID: 6392281
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Antimicrobial therapy and local toxicity of intraventricular administration of vancomycin in a neonate with ventriculitis.
    Nava-Ocampo AA; Mojica-Madera JA; Villanueva-García D; Caltenco-Serrano R
    Ther Drug Monit; 2006 Jun; 28(3):474-6. PubMed ID: 16778737
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Imaging correlates of successful endoscopic third ventriculostomy.
    Kulkarni AV; Drake JM; Armstrong DC; Dirks PB
    J Neurosurg; 2000 Jun; 92(6):915-9. PubMed ID: 10839249
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Exchange of glucose between plasma, brain extracellular fluid and cerebral ventricles in cats and effects of intraventricular acetazolamide and insulin.
    Brondsted HE
    Acta Physiol Scand; 1970 Sep; 80(1):122-30. PubMed ID: 5475324
    [No Abstract]   [Full Text] [Related]  

  • 39. Cerebral ventricular transport and uptake: importance for CCK-mediated satiety.
    Della-Fera MA; Baile CA; Beinfeld MC
    Peptides; 1982; 3(6):963-8. PubMed ID: 7167402
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Complement-derived polypeptide C3adesArg as a mediator of inflammation at the blood-brain barrier in a new experimental cat model.
    Höllerhage HG; Walter GF; Stolke D
    Acta Neuropathol; 1989; 77(3):307-13. PubMed ID: 2922993
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.